Search
for
Sort by
Research 421–450 of 1000+
- Microneedling for Androgenetic Alopecia: A Synergistic Strategy Enhancing Drug Delivery and Follicular Regeneration
- Drug-Induced Hair Loss: Analysis of the Food and Drug Administration’s Adverse Events Reporting System Database
- A bibliometric analysis of alternative drug therapy options in the treatment of androgenetic alopecia
- Drug repurposing—a promising approach for patients with angina but non-obstructive coronary artery disease (ANOCA)
- Solid Lipid Nanoparticles for Drug Delivery: Pharmacological and Biopharmaceutical Aspects
- Logic-based modeling and drug repurposing for the prediction of novel therapeutic targets and combination regimens against E2F1-driven melanoma progression
- Response to “The Role of Patient‐ and Drug‐Related Factors in Oral Minoxidil and Pericardial Effusion: Analyses of Data From the United States Food and Drug Administration Adverse Event Reporting System”
- Roxithromycin-loaded lipid nanoparticles for follicular targeting
- Role of skin enzymes in metabolism of topical drugs
- Alkylation of human hair keratin for tunable hydrogel erosion and drug delivery in tissue engineering applications
- Vandetanib-associated alopecia areata in a patient with metastatic medullary thyroid cancer
- Enhanced therapeutic effects of all-trans retinoic acid nanostructured lipid carrier composite gel drug delivery system for alopecia areata
- A regulatory perspective on pharmacokinetic/pharmacodynamic modelling
- Hidradenitis Suppurativa and Comorbid Disorder Biomarkers, Druggable Genes, New Drugs and Drug Repurposing—A Molecular Meta-Analysis
- Novel Strategies for Androgenetic Alopecia Therapy: Integrating Multifunctional Plant Extracts with Nanotechnology for Advanced Cutaneous Drug Delivery
- Severe Infliximab-Induced Alopecia and Scalp Psoriasis in a Woman with Crohn’s Disease: Dramatic Improvement after Drug Discontinuation and Treatment with Adjuvant Systemic and Topical Therapies
- Long‐term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO‐LT phase 3, open‐label study
- ADVANCES IN PSORIASIS THERAPY
- Original article / Article original Counterfeit drugs and pharmaceutical preparations seized from the black market among bodybuilders Médicaments de contrefaçon et préparations pharmaceutiques saisis sur le marché noir parmi les bodybuilders
- Aplicação da nanotecnologia no tratamento da alopecia
- Lupus erythematosus: systemic and cutaneous manifestations
- Fluoroquinolone-induced serious, persistent, multisymptom adverse effects
- The human gut chemical landscape predicts microbe-mediated biotransformation of foods and drugs
- Experience with sonidegib in patients with advanced basal cell carcinoma: case reports
- Janus Kinase Inhibitors in the Treatment of Alopecia Areata
- Tofacitinib Loaded Squalenyl Nanoparticles for Targeted Follicular Delivery in Inflammatory Skin Diseases
- Minoxidil-induced hypertrichosis in a child with alopecia areata
- Atypical post-finasteride syndrome: A pharmacological riddle
- Therapeutic Response of Alopecia Areata‐Associated Nail Changes to Baricitinib
- Finasteride Treatment of Hair Loss in Women